• 

  FTD 101: Your Being Patient Primer on Frontotemporal Dementia
• 

  Blockbuster GLP-1 Diabetes and Weight Loss Drugs Fails in Alzheimer’s Trial
• 

  Digital Twins: The Sci-Fi Innovation Behind New Personalized Disease Treatments
• 

  Potential First: Pill for Lewy Body Dementia Heads to a Phase 3 Trial
• 

  FDA Clears Blood Test to Help Doctors Rule Out Alzheimer’s
• 

  When Insurance Refused to Cover His Alzheimer’s Treatment, He Found Another Way
• 

  Alzheimer’s Drug Leqembi Approved in Canada
• 

  Cassava Fraud Case Dismissed, Closing a Chapter in Alzheimer’s Drug Saga
• 

  NIH Alzheimer’s Research Funding Is Back — for 49% Fewer Projects
• 

  Cleaner Air, Healthier Brains: Study Links Air Pollution to Alzheimer’s Plaques and Tangles
• 

  Has Fraud Really Hijacked Alzheimer’s Science? Book Review: Charles Piller’s ‘Doctored’
• 

  STUDY: Even Small Amounts of Alcohol Seem to Boost Dementia Risk
• 

  Your Cat’s Brain Could Hold Secrets to Alzheimer’s
• 

  Could Alzheimer’s Drugs Work Better in Pairs? A New Approach for ‘Mabs’
• 

  Gene Therapy ‘First’: Huntington’s Disease Treated in Early Trial

Previous345Next